---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-124000"
form_type: "8-K"
ticker: "ZURA"
cik: "0001855644"
company_name: "Zura Bio Ltd"
filed_at: "2023-12-06T23:59:59+00:00"
generated_at: "2026-06-07T17:24:02.200861+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Zura Bio appoints Dr. Kiran Nistala as EVP, effective Nov 27, 2023

## Summary
- Dr. Nistala appointed Executive Vice President, effective November 27, 2023.
- Annual base salary of GBP £320,000; eligible for discretionary bonus targeting 40% of base.
- Company will recommend grant of 350,000 share options under 2023 Equity Incentive Plan.
- Options vest 1/4 on first anniversary, then 1/36 monthly over 36 months; full vest at 4 years.
- Dr. Nistala previously VP late-stage clinical development at AstraZeneca; also held senior roles at GSK.

## SEC filing metadata
- accession: 0001104659-23-124000
- form_type: 8-K
- ticker: ZURA
- cik: 0001855644
- company_name: Zura Bio Ltd
- filed_at: 2023-12-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855644/000110465923124000/0001104659-23-124000-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855644/000110465923124000/tm2332309d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-124000
- JSON: https://secwatch.observer/filing/0001104659-23-124000.json
- Plain text: https://secwatch.observer/filing/0001104659-23-124000.txt

## Key facts
- Executive change
  Dr. Kiran Nistala was appointed as Executive Vice President at Zura Bio Ltd.
  - Action: appointed
  - Role: Executive Vice President
  source text: On November 30, 2023, Zura Bio Limited (the “Company”) appointed Dr. Kiran Nistala as Executive Vice President, effective as of November 27, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1855644/000110465923124000/0001104659-23-124000-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.